Additional information
by John R. White (Editor)
The 2023-24 Guide to Medications for the Treatment of Diabetes Mellitus is a complete, up-to-date reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide covers all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Chapters cover the management of hyperglycemia in type 1 diabetes and an overview of medications used to treat type 2 diabetes.
Back Jacket
The 2023-24 Guide to Medications for the Treatment of Diabetes Mellitus is a complete, up-to-date reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide covers all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Chapters cover the management of hyperglycemia in type 1 diabetes and an overview of medications used to treat type 2 diabetes.
This guide also includes chapters on medications to manage comorbidities such as:
- Neuropathy
- Nephropathy
- Retinopathy
- Hypoglycemia
- Obesity
- Depression
Author Biography
John R. White, Jr., PA-C, PharmD, is Chair and the R. Keith Campbell Distinguished Professor in Diabetes Care of the Department of Pharmacotherapy at the Washington State University College of Pharmacy. Dr. White is the author of three books, over 30 book chapters, and more than 150 manuscripts on diabetes medications. In addition to his teaching responsibilities at the university, he is a sought-after speaker and has given over 330 lectures at domestic and international conferences. He has been on the editorial boards of many diabetes-related scholarly journals and is currently Associate Editor of Clinical Diabetes.
